Advanced renal cell carcinoma associated with von Hippel-Lindau disease: A case report and review of the literature

Zhang,Lei; Xu,Bin; Wang,Yiduo; Liu,Chunhui; Lu,Kai; Huang,Yeqing; Liu,Ning; Zhang,Xiaowen; Chen,Shuqiu; Chen,Ming

doi:10.3892/ol.2015.3279

Advanced renal cell carcinoma associated with von Hippel-Lindau disease: A case report and review of the literature

Authors:
- Lei Zhang
- Bin Xu
- Yiduo Wang
- Chunhui Liu
- Kai Lu
- Yeqing Huang
- Ning Liu
- Xiaowen Zhang
- Shuqiu Chen
- Ming Chen
View Affiliations

Affiliations: Department of Urology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, P.R. China, Surgical Research Center, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China
Published online on: May 27, 2015 https://doi.org/10.3892/ol.2015.3279
Pages: 1087-1090

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The autosomal dominant hereditary disorder von Hippel-Lindau (VHL) disease is caused by a germline mutation in the VHL gene. The symptoms of VHL include hemangioblastoma of the central nervous system, retinal angiomas, visceral tumors and multiple visceral cysts. However, advanced renal cell carcinoma (RCC) occurs in few VHL patients at initial diagnosis; in addition, sporadic VHL disease with de novo germline mutation is rare. The current study reports the clinical case of a 33‑year‑old Asian male patient diagnosed with advanced bilateral multicentric renal carcinomas. The patient underwent radical nephrectomy with embolectomy of the right kidney for treatment of T3b‑stage RCC and laparoscopic nephron‑sparing surgery of the left kidney. Sunitinib was administered following histological diagnosis and during follow‑up. Genetic analysis revealed a missense mutation, c.194C>G (p.Ser65Trp). In addition, genetic analysis of the patient's parents and brothers, who were unaffected, confirmed a diagnosis of de novo VHL disease. To the best of our knowledge, the present study reports the first known case of a sporadic de novo germline mutation of VHL at c.194C>G. Current understanding of the molecular genetics and pathophysiology of VHL disease, as well as developments in surgical and target therapies for RCC have advanced in recent years; however, early detection through genetic screening and regular clinical surveillance of VHL disease patients and their families continues to be the primary basis for managing the disease.

View Figures

View References

1	Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT and Ferguson-Smith MA: Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 77:1151–1163. 1990. View Article : Google Scholar : PubMed/NCBI
2	Richard S, Graff J, Lindau J and Resche F: Von Hippel-Lindau disease. Lancet. 363:1231–1234. 2004. View Article : Google Scholar : PubMed/NCBI
3	Kaelin WG Jr: Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer. 2:673–682. 2002. View Article : Google Scholar : PubMed/NCBI
4	Neumann HP, Riegler P, Huber W, et al: The challenge of kidney lesions in von Hippel-Lindau disease. Contrib Nephrol. 136:193–207. 2001.PubMed/NCBI
5	Latif F, Tory K, Gnarra J, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1317–1320. 1993. View Article : Google Scholar : PubMed/NCBI
6	Stolle C, Glenn G, Zbar B, et al: Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat. 12:417–423. 1998. View Article : Google Scholar : PubMed/NCBI
7	Chen J, Geng W, Zhao Y, et al: Clinical and mutation analysis of four Chinese families with von Hippel-Lindau disease. Clin Transl Oncol. 15:391–397. 2013. View Article : Google Scholar : PubMed/NCBI
8	Zhang L, Xu B, Chen S, et al: The complex roles of microRNAs in the metastasis of renal cell carcinoma. J Nanosci Nanotechnol. 13:3195–3203. 2013. View Article : Google Scholar : PubMed/NCBI
9	Bradley S, Dumas N, Ludman M and Wood L: Hereditary renal cell carcinoma associated with von Hippel-Lindau disease: a description of a Nova Scotia cohort. Can Urol Assoc J. 3:32–36. 2009.PubMed/NCBI
10	Malek RS, Omess PJ, Benson RC Jr and Zincke H: Renal cell carcinoma in von Hippel-Lindau syndrome. Am J Med. 82:236–238. 1987. View Article : Google Scholar : PubMed/NCBI
11	Choyke PL, Glenn GM, Walther MM, et al: The natural history of renal lesions in von Hippel-Lindau disease: A serial CT study in 28 patients. AJR Am J Roentgenol. 159:1229–1234. 1992. View Article : Google Scholar : PubMed/NCBI
12	Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM and Zbar B: von Hippel-Lindau disease: Genetic, clinical and imaging features. Radiology. 194:629–642. 1995. View Article : Google Scholar : PubMed/NCBI
13	Schips L, Lipsky K, Zigeuner R, Salfellner M, Winkler S, Langner C, Rehak P, Pummer K and Hubmer G: Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: A single-center experience of 683 patients. Urology. 62:1024–1028. 2003. View Article : Google Scholar : PubMed/NCBI
14	Ares Valdés Y: Correlation between symptoms and survival in patients with renal cell carcinoma. Arch Esp Urol. 62:201–206. 2009.(In Spanish). PubMed/NCBI
15	Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM and Oldfield EH: von Hippel-Lindau disease. Lancet. 361:2059–2067. 2003. View Article : Google Scholar : PubMed/NCBI
16	Steinbach F, Novick AC, Zincke H, et al: Treatment of renal cell carcinoma in von Hippel-Lindau disease: A multicenter study. J Urol. 153:1812–1816. 1995. View Article : Google Scholar : PubMed/NCBI
17	Neumann HP, Bender BU, Berger DP, et al: Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol. 160:1248–1254. 1998. View Article : Google Scholar : PubMed/NCBI
18	Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM and Walther MM: The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. 172:63–65. 2004. View Article : Google Scholar : PubMed/NCBI
19	Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL and Walther MM: Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol. 165:777–781. 2001. View Article : Google Scholar : PubMed/NCBI
20	Gill IS, Kavoussi LR, Lane BR, et al: Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 178:41–46. 2007. View Article : Google Scholar : PubMed/NCBI
21	Ljungberg B, Cowan NC, Hanbury DC, et al: EAU guidelines on renal cell carcinoma: The 2010 update. Eur Urol. 58:398–406. 2010. View Article : Google Scholar : PubMed/NCBI
22	Pavlovich CP, Walther M, Choyke PL, Pautler SE, Chang R, Linehan WM and Wood BJ: Percutaneous radio frequency ablation of small renal tumors: Initial results. J Urol. 167:10–15. 2002. View Article : Google Scholar : PubMed/NCBI
23	Gill IS, Remer EM, Hasan WA, et al: Renal cryoablation: Outcome at 3 years. J Urol. 173:1903–1907. 2005. View Article : Google Scholar : PubMed/NCBI
24	Goldfarb DA: Nephron-sparing surgery and renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau. J Intern Med. 243:563–567. 1998. View Article : Google Scholar : PubMed/NCBI
25	Goldfarb DA, Neumann HP, Penn I and Novick AC: Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Transplantation. 64:1726–1729. 1997. View Article : Google Scholar : PubMed/NCBI
26	Knudson AG Jr: Genetics of human cancer. J Cell Physiol. 129 (Suppl 4):7–11. 1986. View Article : Google Scholar
27	Neumann HP and Zbar B: Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int. 51:16–26. 1997. View Article : Google Scholar : PubMed/NCBI
28	Chen F, Kishida T, Yao M, et al: Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype. Hum Mutat. 5:66–75. 1995. View Article : Google Scholar : PubMed/NCBI
29	Crossey PA, Richards FM, Foster K, et al: Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet. 3:1303–1308. 1994. View Article : Google Scholar : PubMed/NCBI
30	Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ and Moore AT: Phenotypic expression in von Hippel-Lindau disease: Correlations with germline VHL gene mutations. J Med Genet. 33:328–332. 1996. View Article : Google Scholar : PubMed/NCBI